Search - tctmd.com

Displaying 101 - 120 of 6216

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1201: National prevalence, temporal trends, and predictors of same day discharge after PCI for NSTE-ACS in clinical practice: A report from the NCDR-CathPCI Registry

Presenter: Sunil V. Rao

October 26, 2025

Presentation TCT 2025

TCT 1198: Discordance Between Treated Artery and Infarct Zone Assessed by Cardiac MRI in NSTEMI Patients with Multivessel Disease: A Single-Center Cohort Study.

Presenter: Arturo Maximiliano Ruiz-Beltran

October 26, 2025

Presentation TCT 2025

TCT 1196: Comparison of Clinical Outcomes Between Incomplete and Complete Revascularization in NSTEMI Patients With Multivessel Disease

Presenter: Chang Hoon Kim

October 26, 2025

Presentation TCT 2025

TCT 1200: Contemporary National Healthcare Disparities, Outcomes, and Risk Predictors of Mortality in Coronary Angiography Utilization in Patients Admitted With NSTEMI

Presenter: Chaitanya Tumuluri

October 26, 2025

Presentation TCT 2025

TCT 1199: Unshielded SQUID MCG for Rapid Detection of Total Coronary Occlusion in Patients with Myocardial Infarction Meeting NSTEMI Criteria

Presenter: Agata Sularz

October 26, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

Presenter: Duk-Woo Park

October 26, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Anticoagulants

Presenter: Schuyler Jones

October 26, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Antiplatelets Duration and SAPT

Presenter: Marco Valgimigli

October 26, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Other Lipid Targets - Lpa and CETP Inhibitors

Presenter: Dharam J. Kumbhani

October 26, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: LDL Lowering Therapies

Presenter: Angelo Oliva

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat!

Presenter: Usman Baber

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Choosing Your SAPT For The Long Haul

Presenter: Marco Valgimigli

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Intraprocedural Therapies - Limitless Choices

Presenter: John A. Bittl

October 26, 2025

Presentation TCT 2025

TCT 675: Intravascular Ultrasonography (IVUS) Versus Angiography-Guided Percutaneous Coronary Intervention (PCI) in Acute Coronary Syndrome (ACS): A Systematic Review and Meta-Analysis

Presenter: Vinay C Bellur

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Pre-treatment - Underrated or Overused?

Presenter: Salvatore Brugaletta

October 26, 2025

Presentation TCT 2025

ACS in the Cath Lab: Deal with Shock: Use Mechanical Circulatory Support or Not?

Presenter: Gregory W. Serrao

October 26, 2025

Presentation TCT 2025

ACS in the Cath Lab: Manage the Clot: Sip or Drip?

Presenter: Ajit R. Menon

October 26, 2025

Presentation TCT 2025

ACS in the Cath Lab: Optimize Stent Outcomes: Use Imaging/Physiology

Presenter: Ricardo A. Costa

October 26, 2025

Presentation TCT 2025

ACS in the Cath Lab: Get the Access Right! Radial First

Presenter: Prashant Kaul

October 26, 2025

News Conference News TCT 2025

Concerto in the Cath Lab: Music Benefits Heart Health After PCI

Michael O'Riordan

October 25, 2025

Advertisement

TCT 1201: National prevalence, temporal trends, and predictors of same day discharge after PCI for NSTE-ACS in clinical practice: A report from the NCDR-CathPCI Registry

TCT 1198: Discordance Between Treated Artery and Infarct Zone Assessed by Cardiac MRI in NSTEMI Patients with Multivessel Disease: A Single-Center Cohort Study.

TCT 1196: Comparison of Clinical Outcomes Between Incomplete and Complete Revascularization in NSTEMI Patients With Multivessel Disease

TCT 1200: Contemporary National Healthcare Disparities, Outcomes, and Risk Predictors of Mortality in Coronary Angiography Utilization in Patients Admitted With NSTEMI

TCT 1199: Unshielded SQUID MCG for Rapid Detection of Total Coronary Occlusion in Patients with Myocardial Infarction Meeting NSTEMI Criteria

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

ACS Pharma Trials On The Horizon: Anticoagulants

ACS Pharma Trials On The Horizon: Antiplatelets Duration and SAPT

ACS Pharma Trials On The Horizon: Other Lipid Targets - Lpa and CETP Inhibitors

ACS Pharma Trials On The Horizon: LDL Lowering Therapies

Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat!

Antithrombotic Therapies in ACS: Choosing Your SAPT For The Long Haul

Antithrombotic Therapies in ACS: Intraprocedural Therapies - Limitless Choices

TCT 675: Intravascular Ultrasonography (IVUS) Versus Angiography-Guided Percutaneous Coronary Intervention (PCI) in Acute Coronary Syndrome (ACS): A Systematic Review and Meta-Analysis

Antithrombotic Therapies in ACS: Pre-treatment - Underrated or Overused?

ACS in the Cath Lab: Deal with Shock: Use Mechanical Circulatory Support or Not?

ACS in the Cath Lab: Manage the Clot: Sip or Drip?

ACS in the Cath Lab: Optimize Stent Outcomes: Use Imaging/Physiology

ACS in the Cath Lab: Get the Access Right! Radial First

Concerto in the Cath Lab: Music Benefits Heart Health After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content